be_ixf;ym_202112 d_03; ct_50

Select Page

Latest Insights on TA

new normal companies to invest in Welcome to the New Normal (3-minute read) Businesses need to adapt to our constantly changing world. And I recently revealed which ones will be the winners throughout the pandemic and beyond…
2022 investing predictions 2 Major Predictions for 2022 Looking forward to 2022, I have two major predictions.
omicron Adagio Therapeutics A Stock-Picking Mutation to Beat the Omicron Threat
by Ted Bauman November 30, 2021 Bauman Daily, Global Economy, News
This is a company that has never made a profit. In fact, it’s never made any money at all. On top of that, analysts expect its per-share losses to double by the end of 2022. Assuming Adagio manages to generate some revenues next year — the market consensus is a minuscule $151 million — it’s already trading at almost 20 times those sales. Why? Because COVID is here to stay … and the search for a response is moving into new areas … quickly.
supply chain not inflation The REAL Supply Chain Problem (NOT Inflation)… In my opinion, we are NOT experiencing inflation right now despite what you might hear in mainstream media.
Two ETF Trades to Beat the Market in December Two ETF Trades to Beat the Market in December It's a new month, which means two free ETF trades from Mike Carr! This time, IWY and XSD ranked at the top of his list...

Newsletter Sign Up

Sponsored

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“My portfolio has grown from 275k to almost 900k with only investments made with Banyan Hill.”

- David G. (Member since 2018)

"I couldn’t believe it … in just 2 months, I made $298,506 on one stock – that’s a 24% gain!"

- John B.

"I went all in with $310,000 and a year later, my portfolio was at $425,000. This I would have never accomplished with mutual funds, I will be following your research for the rest of my life thank you Paul and the team."

- Karl A.

Share This